These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus? Salomão RG; de Carvalho LM; Izumi C; Czernisz ÉS; Rosa JC; Antonini SRR; Bueno AC; Almada MORDV; Coelho-Landell CA; Jordão AA; Ferriani VPL; Monteiro JP Pediatr Rheumatol Online J; 2018 Jan; 16(1):4. PubMed ID: 29316941 [TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ortiz TT; Terreri MT; Caetano M; Souza FS; D'Almeida V; Sarni RO; Hilário MO Ann Nutr Metab; 2013; 63(1-2):77-82. PubMed ID: 23942034 [TBL] [Abstract][Full Text] [Related]
4. Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus. Tso TK; Huang WN Rheumatol Int; 2009 May; 29(7):735-42. PubMed ID: 19037607 [TBL] [Abstract][Full Text] [Related]
7. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Barnes EV; Narain S; Naranjo A; Shuster J; Segal MS; Sobel ES; Armstrong AE; Santiago BE; Reeves WH; Richards HB Lupus; 2005; 14(8):576-82. PubMed ID: 16175928 [TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis. Navarro JF; Mora C; Muros M; García-Idoate G Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Chung CP; Oeser A; Avalos I; Raggi P; Stein CM Lupus; 2006; 15(9):562-9. PubMed ID: 17080910 [TBL] [Abstract][Full Text] [Related]
10. Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients. Karadag O; Calguneri M; Atalar E; Yavuz B; Akdogan A; Kalyoncu U; Bilgen SA; Ozer N; Ertenli AI; Ovunc K; Kiraz S Clin Rheumatol; 2007 May; 26(5):695-9. PubMed ID: 16909327 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the Association Between Carotid Artery Intima-Media Thickness (IMT) and Cardiac Risk Factors in Patients with Systemic Lupus Erythematosus. Rezaieyazdi Z; Sedighi S; Salari M; Fard MH; Azarpazhooh MR; Tabrizi PS; Afshari JT; Saghafi M Curr Rheumatol Rev; 2020; 16(2):125-133. PubMed ID: 31845633 [TBL] [Abstract][Full Text] [Related]
13. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study. Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J; Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus]. Liu L; Zhang T; Ye Y; Zhang S; Chen L Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096 [TBL] [Abstract][Full Text] [Related]
15. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. Mora S; Lee IM; Buring JE; Ridker PM JAMA; 2006 Mar; 295(12):1412-9. PubMed ID: 16551713 [TBL] [Abstract][Full Text] [Related]
16. The impact of obesity on disease activity, damage accrual, inflammation markers and cardiovascular risk factors in systemic lupus erythematosus. Correa-Rodríguez M; Pocovi-Gerardino G; Callejas Rubio JL; Ríos Fernández R; Martín Amada M; Cruz Caparrós M; Ortego-Centeno N; Rueda-Medina B Panminerva Med; 2020 Jun; 62(2):75-82. PubMed ID: 32515571 [TBL] [Abstract][Full Text] [Related]
17. Association of cardiometabolic risk status with clinical activity and damage in systemic lupus erythematosus patients: A cross-sectional study. Campos-López B; Meza-Meza MR; Parra-Rojas I; Ruiz-Ballesteros AI; Vizmanos-Lamotte B; Muñoz-Valle JF; Montoya-Buelna M; Cerpa-Cruz S; Bernal-Hernández LE; De la Cruz-Mosso U Clin Immunol; 2021 Jan; 222():108637. PubMed ID: 33232825 [TBL] [Abstract][Full Text] [Related]
18. Increased concentration of plasma homocysteine in children with systemic lupus erythematosus. do Prado R; D'Almeida VM; Guerra-Shinohara E; Galdieri LC; Terreri MT; Hilário MO Clin Exp Rheumatol; 2006; 24(5):594-8. PubMed ID: 17181933 [TBL] [Abstract][Full Text] [Related]
19. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Ridker PM; Stampfer MJ; Rifai N JAMA; 2001 May; 285(19):2481-5. PubMed ID: 11368701 [TBL] [Abstract][Full Text] [Related]
20. Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study. Zhou B; Xia Y; She J Lipids Health Dis; 2020 Mar; 19(1):40. PubMed ID: 32171306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]